Document 1978 DOCN M94A1978 TI Predicting depression in HIV disorder. HNRC Group. DT 9412 AU Atkinson JH; Patterson TL; Chandler JL; Grant I; Sciolla A; University of California San Diego, Department of Psychiatry; (0603), UCSD School of Medicine, La Jolla 92093-0603. SO Int Conf AIDS. 1994 Aug 7-12;10(1):408 (abstract no. PD0238). Unique Identifier : AIDSLINE ICA10/94370597 AB OBJECTIVE: To determine two year risk and predictors of major depression in human immunodeficiency virus (HIV) infected (HIV+) men and seronegative (HIV-) controls. METHODS: HIV+ (N = 136) and HIV- (N = 44) men participating in a longitudinal cohort study were examined annually for personal and family history of mood disorder (Structured Clinical Interview for DSM-III-R [SCID]; Family History RDC), neuropsychological (NP) status, magnetic resonance imaging (MRI), coping (Ways of Coping), and marked life adversity (Brown & Harris). Likelihood of major depression was computed by survival analysis and predictors were determined from a Cox proportional hazards model. RESULTS: Kaplan-Meier plot for time to major depression indicated overall (HIV+ and HIV-) risk of 7% for each six-month interval on study. Time to episode of depression was related to premorbid history of major depression (logrank test, p < .001) and avoidant coping (p < .01) with life circumstances in the six months preceding the depressive episode, but not to serostatus, NP or MRI abnormality, or family history or life adversity. The two years cumulative risk was 48% for those with past history vs. 19% for those without prior major depression. CONCLUSION: Careful psychiatric history-taking and coping assessment is crucial to identifying high risk for mood disorders in HIV. DE Comparative Study Depression/*EPIDEMIOLOGY Depressive Disorder/*EPIDEMIOLOGY Human HIV Infections/*PSYCHOLOGY *HIV Seronegativity HIV Seropositivity/*PSYCHOLOGY Male Neuropsychological Tests Probability Prognosis Proportional Hazards Models Risk Factors Survival Analysis MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).